Better-Than-Expected Results, Innovation Grants, and Offering Enhancements - Research Report on Thermo Fisher, Covance, LabCorp,

 Better-Than-Expected Results, Innovation Grants, and Offering Enhancements -
  Research Report on Thermo Fisher, Covance, LabCorp, Life Technologies, and
                                   Agilent

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

NEW YORK, November 1, 2013

NEW YORK, November 1, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Thermo
Fisher Scientific Inc. (NYSE: TMO), Covance Inc. (NYSE: CVD), Laboratory
Corporation of America Holdings (NYSE: LH), Life Technologies Corporation
(NASDAQ: LIFE), and Agilent Technologies, Inc. (NYSE: A). Today's readers may
access these reports free of charge - including full price targets, industry
analysis and analyst ratings - via the links below.

Thermo Fisher Scientific Inc. Research Report

On October 23, 2013, Thermo Fisher Scientific Inc. (Thermo Fisher) reported Q3
FY 2013 financial results (period ended September 28, 2013). In Q3 FY 2013,
the Company's revenues increased 3.4% YoY to $3.2 billion. Q3 FY 2013 net
income was $317.6 million, or $0.86 per diluted share, compared with $290.4
million, or $0.79 per diluted share, in Q3 FY 2012. "We executed well in a
challenging market environment, driving productivity and leveraging our PPI
Business System to deliver solid adjusted operating margin expansion," said
Marc N. Casper, President and CEO of Thermo Fisher. "On the technology front,
we had great uptake of our mass spectrometry systems launched at ASMS from
customers in both life sciences and applied markets. In the quarter, we
introduced new technologies to improve bioprocessing quality and efficiency as
well as a new portable analyzer for on-site inspection of animal feed." The
Full Research Report on Thermo Fisher Scientific Inc. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.analystscorner.com/r/full_research_report/45ed_TMO]

--

Covance Inc. Research Report

On October 29, 2013, Covance Inc. (Covance) reported Q3 2013 financial
results. In Q3 2013, the Company reported net revenue of $606.7 million, up
11.4% YoY. Q3 2013 net income was $44.2 million, or $0.78 per share, compared
with $37.8 million, or $0.69 per share, in Q3 2012. "Our better-than-expected
results in the third quarter were driven by exceptional performance in our
central laboratory and continued strong results in clinical development," said
Joe Herring, Chairman and CEO of Covance. Herring added, "Looking ahead to the
fourth quarter of 2013, we expect sequential growth in revenue and operating
income in both our Early and Late-Stage development segments, despite
increased spending on our strategic IT programs." The Full Research Report on
Covance Inc. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.analystscorner.com/r/full_research_report/5691_CVD]

--

Laboratory Corporation of America Holdings Research Report

On October 29, 2013, Laboratory Corporation of America Holdings (LabCorp)
announced that it has priced its offering of $700 million in senior notes. The
Company informed that the offering has two tranches - $400 million aggregate
principal amount of 2.50% Senior Notes due 2018 and $300 million aggregate
principal amount of 4.00% Senior Notes due 2023 - both of which will bear
interest from November 1, 2013. The Company expects the closing of the
offering to be on November 1, 2013, payable semi-annually on November 1 and
May 1, commencing on May 1, 2014. LabCorp plans to use the net proceeds of the
offering for repayment of all or a portion of the outstanding borrowings under
its existing credit facility dated December 21, 2011, as well as for general
corporate purposes. The Full Research Report on Laboratory Corporation of
America Holdings - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
[http://www.analystscorner.com/r/full_research_report/c267_LH]

--

Life Technologies Corporation Research Report

On October 24, 2013, Life Technologies Corporation (Life Technologies)
announced that it has awarded Innovation Grants to five research projects in
the Digital PCR Applications Grant Program, during the American Society for
Human Genetics (ASHG) conference in Boston. The Company informed that each of
the Innovation Grant recipients will receive a QuantStudio 3D Digital PCR
System for research projects that demonstrated innovative applications in
digital PCR. The Full Research Report on Life Technologies Corporation -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.analystscorner.com/r/full_research_report/d5de_LIFE]

--

Agilent Technologies, Inc. Research Report

On October 29, 2013, Agilent Technologies, Inc. (Agilent) announced new
software options for the T4010S LTE RF and T4020S LTE RRM test systems. The
Company informed that the new capabilities will provide coverage for
LTE-Advanced Carrier Aggregation test cases. "We are very excited to further
extend our strong position in wireless test by adding LTE-Advanced
capabilities to our test systems," said Joe DePond, Vice President and General
Manager of Mobile Broadband Operation at Agilent. "Carrier aggregation
represents the immediate future of LTE-Advanced cellular deployments. Our
T4000S systems can now deliver cutting-edge conformance and R&D test solutions
for this important technology." The Full Research Report on Agilent
Technologies, Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
[http://www.analystscorner.com/r/full_research_report/075e_A]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

AnalystsCorner.com

SOURCE Analysts' Corner

Contact: Joe Thomas; +1-310-496-8071 (North America)